Overview

Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease
Phase:
Phase 3
Details
Lead Sponsor:
Abbott
Treatments:
Ergocalciferols
Hormones